Biohaven Statistics
Total Valuation
Biohaven has a market cap or net worth of $1.74 billion. The enterprise value is $1.45 billion.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biohaven has 102.11 million shares outstanding. The number of shares has increased by 29.20% in one year.
Current Share Class | 102.11M |
Shares Outstanding | 102.11M |
Shares Change (YoY) | +29.20% |
Shares Change (QoQ) | +0.88% |
Owned by Insiders (%) | 11.54% |
Owned by Institutions (%) | 85.12% |
Float | 84.70M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 28.70 |
PB Ratio | 6.37 |
P/TBV Ratio | 7.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.14.
Current Ratio | 2.33 |
Quick Ratio | 1.97 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -316.82% and return on invested capital (ROIC) is -181.93%.
Return on Equity (ROE) | -316.82% |
Return on Assets (ROA) | -129.99% |
Return on Invested Capital (ROIC) | -181.93% |
Return on Capital Employed (ROCE) | -309.43% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.47M |
Employee Count | 256 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Biohaven has paid $775,000 in taxes.
Income Tax | 775,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.34% in the last 52 weeks. The beta is 3.64, so Biohaven's price volatility has been higher than the market average.
Beta (5Y) | 3.64 |
52-Week Price Change | -51.34% |
50-Day Moving Average | 19.19 |
200-Day Moving Average | 35.85 |
Relative Strength Index (RSI) | 46.37 |
Average Volume (20 Days) | 2,330,948 |
Short Selling Information
The latest short interest is 8.17 million, so 8.00% of the outstanding shares have been sold short.
Short Interest | 8.17M |
Short Previous Month | 7.69M |
Short % of Shares Out | 8.00% |
Short % of Float | 9.65% |
Short Ratio (days to cover) | 3.38 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -912.53M |
Pretax Income | -750.36M |
Net Income | -888.60M |
EBITDA | -903.88M |
EBIT | -912.53M |
Earnings Per Share (EPS) | -$9.23 |
Full Income Statement Balance Sheet
The company has $322.75 million in cash and $35.51 million in debt, giving a net cash position of $287.24 million or $2.81 per share.
Cash & Cash Equivalents | 322.75M |
Total Debt | 35.51M |
Net Cash | 287.24M |
Net Cash Per Share | $2.81 |
Equity (Book Value) | 259.50M |
Book Value Per Share | 2.54 |
Working Capital | 218.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$644.94 million and capital expenditures -$4.07 million, giving a free cash flow of -$649.01 million.
Operating Cash Flow | -644.94M |
Capital Expenditures | -4.07M |
Free Cash Flow | -649.01M |
FCF Per Share | -$6.36 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biohaven does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.20% |
Shareholder Yield | -29.20% |
Earnings Yield | -51.20% |
FCF Yield | -37.40% |
Dividend Details Analyst Forecast
The average price target for Biohaven is $59.85, which is 251.44% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $59.85 |
Price Target Difference | 251.44% |
Analyst Consensus | Strong Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 6.05% |
EPS Growth Forecast (5Y) | -23.29% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |